{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:21:12Z","timestamp":1721348472937},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,18]]},"DOI":"10.7759\/cureus.64858","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T21:34:05Z","timestamp":1721338445000},"source":"Crossref","is-referenced-by-count":0,"title":["A 27-Year-Old Female With JAK2 Mutation: A Case of Budd-Chiari Syndrome Secondary to Prolonged Oral Contraceptive Pill Use"],"prefix":"10.7759","author":[{"given":"John P","family":"Karns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"True-Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Smythe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghavendra","family":"Vemulapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1800","article-title":"JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia","volume":"106","author":"Jelinek J","year":"2005","unstructured":"Jelinek J, Oki Y, Gharibyan V, et al.. JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia. Blood. 2005, 106:3370-3. 10.1182\/blood-2005-05-1800","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2210","article-title":"Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders","volume":"7","author":"Levine RL","year":"2007","unstructured":"Levine RL, Pardanani A, Tefferi A, Gilliland DG. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer. 2007, 7:673-83. 10.1038\/nrc2210","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.033191","article-title":"The JAK2 V617F somatic mutation, mortality and cancer risk in the general population","volume":"96","author":"Nielsen C","year":"2011","unstructured":"Nielsen C, Birgens HS, Nordestgaard BG, Kjaer L, Bojesen SE. The JAK2 V617F somatic mutation, mortality and cancer risk in the general population. Haematologica. 2011, 96:450-3. 10.3324\/haematol.2010.033191","journal-title":"Haematologica"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine RL","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J, et al.. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005, 7:387-97. 10.1016\/j.ccr.2005.03.023","journal-title":"Cancer Cell"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James C","year":"2005","unstructured":"James C, Ugo V, Le Cou\u00e9dic JP, et al.. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005, 434:1144-8. 10.1038\/nature03546","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter EJ","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, et al.. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005, 365:1054-61. 10.1016\/S0140-6736(05)71142-9","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1816082","article-title":"Essential thrombocythemia","volume":"381","author":"Tefferi A","year":"2019","unstructured":"Tefferi A, Pardanani A. Essential thrombocythemia. N Engl J Med. 2019, 381:2135-44. 10.1056\/NEJMcp1816082","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.813500","article-title":"Epidemiology of myeloproliferative neoplasms in the United States","volume":"55","author":"Mehta J","year":"2014","unstructured":"Mehta J, Wang H, Iqbal SU, Mesa R. Epidemiology of myeloproliferative neoplasms in the United States. Leuk Lymphoma. 2014, 55:595-600. 10.3109\/10428194.2013.813500","journal-title":"Leuk Lymphoma"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.33756","article-title":"The risk of thrombosis in essential thrombocythemia and polycythemia vera","volume":"29","author":"Pearson TC","year":"2002","unstructured":"Pearson TC. The risk of thrombosis in essential thrombocythemia and polycythemia vera. Semin Oncol. 2002, 29:16-21. 10.1053\/sonc.2002.33756","journal-title":"Semin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000175153","article-title":"Leukocytosis, JAK2V617F mutation, and hemostasis in myeloproliferative disorders","volume":"36","author":"Marchetti M","year":"2008","unstructured":"Marchetti M, Falanga A. Leukocytosis, JAK2V617F mutation, and hemostasis in myeloproliferative disorders. Pathophysiol Haemost Thromb. 2008, 36:148-59. 10.1159\/000175153","journal-title":"Pathophysiol Haemost Thromb"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v14.i3.99","article-title":"Budd-Chiari syndrome in myeloproliferative neoplasms: a review of literature","volume":"14","author":"G\u0103man MA","year":"2023","unstructured":"G\u0103man MA, Cozma MA, Manan MR, et al.. Budd-Chiari syndrome in myeloproliferative neoplasms: a review of literature. World J Clin Oncol. 2023, 14:99-116. 10.5306\/wjco.v14.i3.99","journal-title":"World J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.05.008","article-title":"Estrogen and thrombosis: a bench to bedside review","volume":"192","author":"Abou-Ismail MY","year":"2020","unstructured":"Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: a bench to bedside review. Thromb Res. 2020, 192:40-51. 10.1016\/j.thromres.2020.05.008","journal-title":"Thromb Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/2040620716680333","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease","volume":"8","author":"How J","year":"2017","unstructured":"How J, Zhou A, Oh ST. Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease. Ther Adv Hematol. 2017, 8:107-18. 10.1177\/2040620716680333","journal-title":"Ther Adv Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010813.pub2","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos M","year":"2014","unstructured":"de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014, 2014:CD010813. 10.1002\/14651858.CD010813.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90032-2","article-title":"Liver cell necrosis: cellular mechanisms and clinical implications","volume":"108","author":"Rosser BG","year":"1995","unstructured":"Rosser BG, Gores GJ. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology. 1995, 108:252-75. 10.1016\/0016-5085(95)90032-2","journal-title":"Gastroenterology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261471-a-27-year-old-female-with-jak2-mutation-a-case-of-budd-chiari-syndrome-secondary-to-prolonged-oral-contraceptive-pill-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T21:34:08Z","timestamp":1721338448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261471-a-27-year-old-female-with-jak2-mutation-a-case-of-budd-chiari-syndrome-secondary-to-prolonged-oral-contraceptive-pill-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.64858","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,18]]}}}